This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Nyvold CG, Stentoft J, Braendstrup K, Melsvik D, Moestrup SK, Juhl-Christensen C et al. Wilms' tumor 1 mutation accumulated during therapy in acute myeloid leukemia: biological and clinical implications. Leukemia 2006; 20: 2051–2054.
Summers K, Stevens J, Kakkas I, Smith M, Smith LL, MacDougall F et al. Wilms' tumour 1 (WT1) mutations are associated with FLT3-ITD and failure of standard induction chemotherapy in patients with normal karyotype AML. Leukemia 4 January 2007 [E-pub ahead of print].
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nyvold, C., Ommen, H., Østergaard, M. et al. Reply to ‘Wilms' tumour 1 mutations are associated with FLT3-ITD and failure of standard induction chemotherapy in patients with normal karyotype AML’ by Summers et al.. Leukemia 21, 552 (2007). https://doi.org/10.1038/sj.leu.2404515
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404515